Cartesian Therapeutics vs Shattuck Labs
RNAC and STTK side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RNAC and STTK compare
Shattuck Labs is the larger company, worth 2.4 times as much as Cartesian Therapeutics ($507M against $208M).
Shattuck Labs scores higher on the StockData Score (8 against 1 for Cartesian Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RNAC | STTK |
|---|---|---|
| Size and price | ||
| Market cap | $208M | $507M |
| Share price | $6.89 | $5.05 |
| Change, 1 year | −12.5% | 167% |
| Change, 5 years | −92.8% | −46.3% |
| Beta (5Y) | 1.42 | 1.63 |
| Employees | 75 | 40 |
| StockData Score | ||
| Total score | 1 | 8 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 203× | – |
| P/B | – | 2.6× |
| FCF yield | −43.1% | – |
| Growth | ||
| Revenue growth (TTM) | – | −100% |
| Revenue growth, 5Y average | −30.0% (better) | −36.8% |
| Profitability | ||
| Operating margin | −15541% | – |
| Net margin | −12435% | – |
| FCF margin | −8770% | – |
| Return on equity | – | −47.2% |
| Return on invested capital | – | −2531% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | 8.38 | 15.80 (better) |
| Altman Z-score | −5.09 | 17.92 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −19.9% |
| Shareholder yield | 0.00% (better) | −19.9% |
| Ownership | ||
| Held by institutions | 29.3% | 83.5% |
| Held by insiders | 55.7% | 24.1% |
| Insider net buying, 12 months | −$52.9K (better) | −$342K |
| Short interest, % of float | 14.3% | 14.1% |
Go deeper
- RNAC stock overview
- RNAC income statement
- RNAC valuation and score
- STTK stock overview
- STTK income statement
- STTK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.